LIMNW stock · PFG stock

LIMNW vs PFG

Liminatus Pharma, Inc. Warrants (LIMNW) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.

Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.

Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.

LIMNW does not have a complete income-statement cache yet.

Latest reported PFG revenue for 2025-12-31 was $15.63B. Net income was $1.19B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.

LIMNW currently screens at market cap $0. PFG currently screens at market cap $23.81B and trailing P/E 15.8.

Not investment advice. Open the LIMNW and PFG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons